AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 101 min read$KIDS

Pelizzon David R sold $6.4M of KIDS (indirect holdings)

Pelizzon David R sold 302,369 indirectly-held shares of ORTHOPEDIATRICS CORP (KIDS) at $21.01 ($6.35M total) on 2026-09-10.

Original reporting
SEC EDGAR · Pelizzon David R
Published Sep 10, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishLow
01

Why it matters

The sale reduces insider ownership, potentially influencing investor sentiment.

02

Market read

First‑report insider sale of over $6M; modest relevance for traders monitoring insider activity.

03

What to watch

No disclosed reason for sale; could be personal liquidity need or tax planning.

Relevance 6/10Novelty 7/10Timing: today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

Director Pelizzon sold 302,369 shares for $6.35M, reducing his stake to 6.2M shares.

Expected impact

Possible modest decline in the next few days.

Evidence & confidence

Large insider sale by a 10% owner, but no accompanying news; market may interpret as a negative signal.

Market effects

Sector

May affect perception of the orthopedics device sector if other insiders follow suit.

Regional

Limited to U.S. investors focused on small-cap healthcare stocks.

Global

Minimal global impact; primarily a company‑specific event.

Counterpoint

What could challenge this read

Insider may be diversifying; sale does not necessarily reflect company fundamentals.

Key entities

  • Company
    Orthopedics Corp

    Ticker KIDS, a U.S.-listed orthopedics device manufacturer.

  • Insider
    Pelizzon David R

    Director and 10% owner of Orthopedics Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

KIDS insider trading history →

Related articles

SEP 11
$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

insidermonkey.com2 min
AUG 6
$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.

yahoo.com7 min